跳至主要内容
临床试验/NCT00669357
NCT00669357No Longer Available不适用

AbioCor Implantable Replacement Heart

Abiomed Inc.0 个研究点开始时间: 2008年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
No Longer Available
发起方
Abiomed Inc.

研究概览

简要总结

Abiocor is a post market approval study for an Implantable Replacement Heart. This post approval study is currently on hold.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients in severe biventricular end stage heart disease who are not cardiac transplant candidates and who are adults less than 75 years old, require multiple inotropic support, are not treatable by LVAD destination therapy, and are not weanable from biventricular support if on such support.

排除标准

  • •Patients with other irreversible end organ dysfunctions that would compromise survival, having in clinical assessment a more than 30% chance of survival beyond 30 days, inadequate psychosocial support, or patients in whom fit is a problem, based on preoperative noninvasive anatomical assessment showing that the thoracic volume is unable to accommodate the device.

研究者

发起方
Abiomed Inc.
申办方类型
Industry
责任方
Sponsor

相似试验